None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged between 20 and 75 years Participants who voluntarily agreed to participate and provided written informed consent Participants able to comply with the study protocol during the study period Participants with white blood cell counts within the normal reference range Participants with a Perceived Stress Scale (PSS) score of 18 or higher
Exclusion criteria
Exclusion criteria: Participants with serious medical conditions that could affect study outcomes Participants taking medications or supplements related to immune function Participants with hypersensitivity to the investigational product ingredients Participants considered unsuitable for study participation by the investigator Pregnant or breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Natural Killer (NK) Cell Activity Changes | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in TNF-a, IFN-?, WBC, IgE, IL-1ß, IL-2, IL-6, and IL-12 | — |
Countries
Korea, Republic of
Contacts
Pusan National University Hospital